Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/49845
Campo DC Valoridioma
dc.contributor.authorBoronat, Mauroen_US
dc.contributor.authorChirino, R.en_US
dc.contributor.authorVarillas, V. F.en_US
dc.contributor.authorSaavedra Santana, Pedroen_US
dc.contributor.authorMarrero, D.en_US
dc.contributor.authorFabregas, M.en_US
dc.contributor.authorNóvoa, F. J.en_US
dc.date.accessioned2018-11-24T11:11:20Z-
dc.date.available2018-11-24T11:11:20Z-
dc.date.issued2005en_US
dc.identifier.issn0742-3071en_US
dc.identifier.urihttp://hdl.handle.net/10553/49845-
dc.description.abstractAims The present study was conducted to estimate the prevalence of the metabolic syndrome in a Canarian population, and to compare its frequency as defined by the most commonly used working definitions.Methods Cross-sectional population-based study. One thousand and thirty adult subjects were randomly selected from the local census of Telde, a city located on the island of Gran Canaria. Participants completed a survey questionnaire and underwent physical examination, fasting blood analyses, and a 75-g standardized oral glucose tolerance test. The prevalence of the metabolic syndrome was estimated according to the definitions proposed by the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR) and the National Cholesterol Education Program (NCEP), the latter with the original (6.1 mmol/l) and the revised criterion (5.6 mmol/l) for abnormal fasting glucose.Results The adjusted prevalence of the metabolic syndrome was 28.0, 15.9, 23.0 and 28.2%, using the WHO, EGIR, NCEP and revised NCEP criteria, respectively. The measure of agreement (kappa statistic) was 0.57 between the WHO and the original NCEP definitions, and 0.61 between the WHO and the revised NCEP definitions. After excluding diabetic subjects, the agreement between the EGIR and WHO proposals was fairly good (kappa = 0.70), whereas concordance of the EGIR with the original and the revised NCEP definitions was moderate (kappa = 0.47 and 0.46, respectively).Conclusions Whichever the considered diagnostic criteria, the prevalence of the metabolic syndrome in this area of the Canary Islands is greater than that observed in most other European populations.en_US
dc.languageengen_US
dc.relation.ispartofDiabetic Medicineen_US
dc.sourceDiabetic Medicine[ISSN 0742-3071],v. 22, p. 1751-1756en_US
dc.subject32 Ciencias médicasen_US
dc.subject3206 Ciencias de la nutriciónen_US
dc.subject.otherInsulin-Resistanceen_US
dc.subject.otherPopulationen_US
dc.subject.otherDefinitionsen_US
dc.subject.otherHearten_US
dc.titlePrevalence of the metabolic syndrome in the island of Gran Canaria: Comparison of three major diagnostic proposalsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/j.1464-5491.2005.01745.xen_US
dc.identifier.scopus30044433755-
dc.identifier.isi000233714800020-
dc.contributor.authorscopusid7003952293-
dc.contributor.authorscopusid6701324062-
dc.contributor.authorscopusid12786819300-
dc.contributor.authorscopusid56677724200-
dc.contributor.authorscopusid54080032500-
dc.contributor.authorscopusid14520381500-
dc.contributor.authorscopusid12786120600-
dc.description.lastpage1756en_US
dc.description.firstpage1751en_US
dc.relation.volume22en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid673494-
dc.contributor.daisngid1922831-
dc.contributor.daisngid5465027-
dc.contributor.daisngid2994410-
dc.contributor.daisngid107153-
dc.contributor.daisngid8129195-
dc.contributor.daisngid556390-
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Boronat, M-
dc.contributor.wosstandardWOS:Chirino, R-
dc.contributor.wosstandardWOS:Varillas, VF-
dc.contributor.wosstandardWOS:Saavedra, P-
dc.contributor.wosstandardWOS:Marrero, D-
dc.contributor.wosstandardWOS:Fabregas, M-
dc.contributor.wosstandardWOS:Novoa, FJ-
dc.date.coverdateDiciembre 2005en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr2,725-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR Estadística-
crisitem.author.deptDepartamento de Matemáticas-
crisitem.author.orcid0000-0001-8535-8543-
crisitem.author.orcid0000-0002-5681-8931-
crisitem.author.orcid0000-0003-1681-7165-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgDepartamento de Matemáticas-
crisitem.author.fullNameBoronat Cortés, Mauro-
crisitem.author.fullNameChirino Godoy, Ricardo-
crisitem.author.fullNameSaavedra Santana, Pedro-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

28
actualizado el 21-abr-2024

Citas de WEB OF SCIENCETM
Citations

25
actualizado el 25-feb-2024

Visitas

74
actualizado el 28-oct-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.